Benzinga | Mar 29, 2021 04:06PM EDT

Biocept Q4 Sales $18.50M Beat $12.32M Estimate

Biocept (NASDAQ:BIOC) reported quarterly sales of $18.50 million which beat the analyst consensus estimate of $12.32 million by 50.16 percent. This is a 937.00 percent increase over sales of $1.78 million the same period last year.